QA: Ocata Therapeutics Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001140098_2013_Ocata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning NetIncome node detected by IncomeLoss name heuristic input.sec.calculation_linkbase.edgar_model_mapping {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001140098, Ocata Therapeutics Inc

  xvar xval
0 AssetsCurrent 7,552,756
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 175,256
3 remainder_Assets 768,530
4 LiabilitiesCurrent 22,204,782
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 6,551,988
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,452,230
9 ResearchAndDevelopmentExpense 11,034,836
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -7,039,195
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,496,542
1 Liabilities 28,756,770
2 Expenses 21,487,066
3 Revenues 0
4 StockholdersEquity -20,260,228
5 NetIncome -28,526,261
6 ComprehensiveNetIncome -28,526,261
7 BaseVar 32,889,786
8 EconomicCapitalRatiobeforeLimitedLiability -3.90
9 EconomicCapitalRatio 0.417

Edgar->Model Mapping

Feature Distribution

Change over Time